Literature DB >> 18207021

COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs.

Timothy D Warner1, Jane A Mitchell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207021     DOI: 10.1016/S0140-6736(08)60137-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  46 in total

1.  High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents.

Authors:  K V Greco; A J Iqbal; L Rattazzi; G Nalesso; N Moradi-Bidhendi; A R Moore; M B Goldring; F Dell'Accio; M Perretti
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

Review 2.  Analgesic targets: today and tomorrow.

Authors:  Ian W Rodger
Journal:  Inflammopharmacology       Date:  2009-06-09       Impact factor: 4.473

3.  Osteoarthritis: a holistic approach.

Authors:  Andrew Barr; Philip G Conaghan
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

4.  [New substances and applications for postoperative pain therapy].

Authors:  E M Pogatzki-Zahn; P K Zahn
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 5.  [Concepts for perioperative pain therapy. A critical stocktaking].

Authors:  S Reichl; E Pogatzki-Zahn
Journal:  Anaesthesist       Date:  2009-09       Impact factor: 1.041

6.  New insights into structural determinants for prostanoid thromboxane A2 receptor- and prostacyclin receptor-G protein coupling.

Authors:  Raja Chakraborty; Sai Prasad Pydi; Scott Gleim; Rajinder Pal Bhullar; John Hwa; Shyamala Dakshinamurti; Prashen Chelikani
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

Review 7.  Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Authors:  Daniel J Hermanson; Joyonna C Gamble-George; Lawrence J Marnett; Sachin Patel
Journal:  Trends Pharmacol Sci       Date:  2014-05-18       Impact factor: 14.819

8.  Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.

Authors:  Gregory Castelli; Ashley Petrone; Jun Xiang; Carl Shrader; Dana King
Journal:  Am J Cardiovasc Drugs       Date:  2017-06       Impact factor: 3.571

Review 9.  Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.

Authors:  Matthias Hermann
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

10.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.